Cargando…

Author Correction: Analysis of chemotherapy-induced peripheral neuropathy using the Japanese Adverse Drug Event Report database

Detalles Bibliográficos
Autores principales:	Inoue, Misaki, Matsumoto, Kiyoka, Tanaka, Mizuki, Yoshida, Yu, Satake, Riko, Goto, Fumiya, Shimada, Kazuyo, Mukai, Ririka, Hasegawa, Shiori, Suzuki, Takaaki, Ikesue, Hiroaki, Liao, Jun, Hashida, Tohru, Nakamura, Mitsuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705710/ https://www.ncbi.nlm.nih.gov/pubmed/36443370 http://dx.doi.org/10.1038/s41598-022-24702-8

Ejemplares similares

Analysis of chemotherapy-induced peripheral neuropathy using the Japanese Adverse Drug Event Report database
por: Inoue, Misaki, et al.
Publicado: (2021)

Analysis of immune‐related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database
por: Hasegawa, Shiori, et al.
Publicado: (2020)

Assessment of Reye’s syndrome profile with data from the US Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databases using the disproportionality analysis
por: Matsumoto, Kiyoka, et al.
Publicado: (2020)

Analysis of Drug-Induced Gastrointestinal Obstruction and Perforation Using the Japanese Adverse Drug Event Report Database
por: Satake, Riko, et al.
Publicado: (2021)

Evaluation of anti-infective-related Clostridium difficile-associated colitis using the Japanese Adverse Drug Event Report database
por: Nakao, Satoshi, et al.
Publicado: (2020)

Pharmacovigilance study of anti-infective-related acute kidney injury using the Japanese adverse drug event report database
por: Nakao, Satoshi, et al.
Publicado: (2021)

Analysis of drug-induced hand–foot syndrome using a spontaneous reporting system database
por: Yoshida, Yu, et al.
Publicado: (2022)

Osteonecrosis of the Jaw Caused by Denosumab in Treatment-Naïve and Pre-Treatment with Zoledronic Acid Groups: A Time-to-Onset Study Using the Japanese Adverse Drug Event Report (JADER) Database
por: Hasegawa, Shiori, et al.
Publicado: (2022)

Analysis of drug-induced hearing loss by using a spontaneous reporting system database
por: Tanaka, Mizuki, et al.
Publicado: (2019)

Analysis of drug-induced interstitial lung disease using the Japanese Adverse Drug Event Report database
por: Matsumoto, Kiyoka, et al.
Publicado: (2020)

Gentamicin-induced hearing loss: A retrospective study using the Food and Drug Administration Adverse Event Reporting System and a toxicological study using drug−gene network analysis
por: Tanaka, Mizuki, et al.
Publicado: (2021)

Adverse reaction profiles of hemorrhagic adverse reactions caused by direct oral anticoagulants analyzed using the Food and Drug Administration Adverse Event Reporting System (FAERS) database and the Japanese Adverse Drug Event Report (JADER) database
por: Shimada, Kazuyo, et al.
Publicado: (2019)

Analysis of fall-related adverse events among older adults using the Japanese Adverse Drug Event Report (JADER) database
por: Hatahira, Haruna, et al.
Publicado: (2018)

Promoting generic drug usage in Japan: correlation between generic drug usage and monthly personal income
por: Suzuki, Takaaki, et al.
Publicado: (2023)

Risk factors of proteinuria and potentially protective effect of renin–angiotensin system inhibitors in patients with renal cell carcinoma receiving axitinib
por: Ikesue, Hiroaki, et al.
Publicado: (2022)

Safety and efficacy evaluation of low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis pneumonia in HIV uninfected patients undergoing hemodialysis: a retrospective observational study
por: Yamashita, Kanae, et al.
Publicado: (2021)

Interaction between warfarin and short-term intravenous amiodarone in intensive care unit patients after cardiac surgery
por: Takase, Tomoki, et al.
Publicado: (2018)

Effect of the number of dose adjustment factors on bleeding risk in patients receiving 30 mg/day edoxaban
por: Takase, Tomoki, et al.
Publicado: (2019)

Association between 25-hydroxyvitamin D levels and COVID-19 severity
por: Takase, Tomoki, et al.
Publicado: (2022)

Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score–matched analysis
por: Ikesue, Hiroaki, et al.
Publicado: (2021)

Polypharmacy-associated potential contraindications of drug prescriptions in patients with primary angle closure disease in a real-world setting
por: Tanaka, Fumiaki, et al.
Publicado: (2021)

Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases
por: Ikesue, Hiroaki, et al.
Publicado: (2021)

Evaluation of pharmaceutical intervention in direct-acting antiviral agents for hepatitis C virus infected patients in an ambulatory setting: a retrospective analysis
por: Yamamoto, Haruna, et al.
Publicado: (2018)

Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID‐19
por: Irie, Kei, et al.
Publicado: (2020)

Pharmacist-Urologist Collaborative Management Improves Clinical Outcomes in Patients With Castration-Resistant Prostate Cancer Receiving Enzalutamide
por: Hirabatake, Masaki, et al.
Publicado: (2022)

Safety and blood levels of daratumumab after switching from intravenous to subcutaneous administration in patients with multiple myeloma
por: Yamaoka, Kenta, et al.
Publicado: (2023)

Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the Food and Drug Administration Adverse Event Reporting System
por: Naganuma, Misa, et al.
Publicado: (2019)

Paget's Disease of Bone Presenting with Peripheral Neuropathy
por: Misaki, Moriharu, et al.
Publicado: (2017)

Population pharmacokinetics of favipiravir in patients with COVID‐19
por: Irie, Kei, et al.
Publicado: (2021)

Population pharmacokinetics and exposure–clinical outcome relationship of remdesivir major metabolite GS‐441524 in patients with moderate and severe COVID‐19
por: Tamura, Ryo, et al.
Publicado: (2023)

Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network
por: Umetsu, Ryogo, et al.
Publicado: (2021)

A Drosophila model of the neurological symptoms in Mpv17-related diseases
por: Kodani, Atsushi, et al.
Publicado: (2022)

Population Pharmacokinetics of Nivolumab in Japanese Patients with Nonsmall Cell Lung Cancer
por: Tohi, Makiko, et al.
Publicado: (2023)

Pharmacokinetics of Temozolomide in a Patient With Glioblastoma Undergoing Hemodialysis: A Short Communication
por: Tanaka, Fumiaki, et al.
Publicado: (2023)

Author Correction: Propagation and Selectivity of Axonal Loss in Leber Hereditary Optic Neuropathy
por: Coussa, Razek Georges, et al.
Publicado: (2020)

Evaluation of the usefulness of protocol‐based pharmacist‐facilitated laboratory monitoring to ensure the safety of immune checkpoint inhibitors in patients with lung cancer
por: Ikesue, Hiroaki, et al.
Publicado: (2020)

Evaluating the safety and efficiency of robotic dispensing systems
por: Takase, Tomoki, et al.
Publicado: (2022)

TAMable tumor-associated macrophages in response to innate RNA sensing
por: Seya, Tsukasa, et al.
Publicado: (2012)

Author Correction: Clinical and laboratory features of anti-MAG neuropathy without monoclonal gammopathy
por: Pascual-Goñi, Elba, et al.
Publicado: (2021)

Quantitative Evaluation of Drug Resistance Profile of Cells Expressing Wild-Type or Genetic Polymorphic Variants of the Human ABC Transporter ABCC4
por: Tsukamoto, Megumi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_me3nslsu5o2i71c4d65li506qr